ArticleThe American journal of case reports2017

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease.

Tajda Keber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.